Callan JMB Upgrades Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring
Callan JMB (NASDAQ:CJMB) announced Sentry 4.0, an upgraded version of its Sentry Monitoring System for temperature-sensitive pharmaceutical storage on Oct 13, 2025.
Sentry 4.0 replaces Java with HTML5, enabling access from any web browser on PC, Mac, iPhone, Android, or tablet without downloads. The system retains 24/7/365 active monitoring, alarm notifications, and compliant reporting while improving user accessibility and consistency across devices. The upgrade is available now to new and existing customers.
Callan JMB (NASDAQ:CJMB) ha annunciato Sentry 4.0, una versione aggiornata del suo Sentry Monitoring System per la conservazione di prodotti farmaceutici sensibili alla temperatura il 13 ottobre 2025.
Sentry 4.0 sostituisce Java con HTML5, consentendo l'accesso da qualsiasi browser web su PC, Mac, iPhone, Android o tablet senza download. Il sistema mantiene monitoraggio attivo 24/7/365, notifiche di allarme e report conformi, migliorando l'accessibilità per l'utente e la coerenza tra i dispositivi. L'aggiornamento è disponibile ora per nuovi clienti e per quelli esistenti.
Callan JMB (NASDAQ:CJMB) anunció Sentry 4.0, una versión mejorada de su Sentry Monitoring System para el almacenamiento farmacéutico sensible a la temperatura, el 13 de octubre de 2025.
Sentry 4.0 reemplaza Java por HTML5, lo que permite acceder desde cualquier navegador web en PC, Mac, iPhone, Android o tableta sin descargas. El sistema mantiene un monitorizado activo 24/7/365, notificaciones de alarma y generación de informes conforme, mientras mejora la accesibilidad del usuario y la consistencia entre dispositivos. La actualización ya está disponible para nuevos y actuales clientes.
Callan JMB (NASDAQ:CJMB)가 Sentry 4.0를 발표했습니다. 이는 체온에 민감한 의약품 보관을 위한 Sentry Monitoring System의 업그레이드 버전으로 2025년 10월 13일에 발표되었습니다.
Sentry 4.0은 Java를 HTML5로 대체하여 PC, Mac, iPhone, Android 또는 태블릿에서 다운로드 없이 모든 웹 브라우저에서 접속할 수 있습니다. 이 시스템은 24/7/365 활성 모니터링, 경고 알림, 준수 보고를 유지하면서 사용자 접근성과 기기간 일관성을 향상시킵니다. 업그레이드는 신규 및 기존 고객에게 지금 바로 제공됩니다.
Callan JMB (NASDAQ:CJMB) a annoncé Sentry 4.0, une version améliorée de son Sentry Monitoring System pour le stockage pharmaceutique sensible à la température le 13 octobre 2025.
Sentry 4.0 remplace Java par HTML5, permettant l'accès depuis n'importe quel navigateur web sur PC, Mac, iPhone, Android ou tablette sans téléchargement. Le système conserve un monitoring actif 24/7/365, des notifications d'alarme et des rapports conformes tout en améliorant l'accessibilité utilisateur et la cohérence entre les appareils. La mise à jour est dès à présent disponible pour les nouveaux et les clients existants.
Callan JMB (NASDAQ:CJMB) hat am 13. Oktober 2025 Sentry 4.0 angekündigt, eine aktualisierte Version seines Sentry Monitoring System für die temperaturempfindliche pharmazeutische Lagerung.
Sentry 4.0 ersetzt Java durch HTML5, sodass der Zugriff von jedem Webbrowser auf PC, Mac, iPhone, Android oder Tablet ohne Downloads möglich ist. Das System behält 24/7/365 aktive Überwachung, Alarmbenachrichtigungen und konforme Berichte bei, während Benutzerzugänglichkeit und Konsistenz über Geräte verbessert werden. Das Upgrade ist jetzt für neue und bestehende Kunden verfügbar.
Callan JMB (NASDAQ:CJMB) أعلن عن Sentry 4.0، إصداراً مطوراً من نظام Sentry Monitoring لتخزين الأدوية الحساسة لدرجة الحرارة في 13 أكتوبر 2025.
Sentry 4.0 يستبدل Java بـ HTML5، مما يتيح الوصول من أي متصفح ويب على الكمبيوتر الشخصي أو ماك أو iPhone أو Android أو جهاز لوحي بدون تنزيلات. يظل النظام يتيح المراقبة الفعالة 24/7/365، وإشعارات الإنذار، والتقارير المتوافقة، مع تحسين سهولة وصول المستخدم والاتساق عبر الأجهزة. الترقية متاحة الآن للعملاء الجدد والموجودين.
Callan JMB (NASDAQ:CJMB) 宣布了 Sentry 4.0,这是其用于对温度敏感药品存储的 Sentry 监控系统的升级版本,发布于 2025 年 10 月 13 日。
Sentry 4.0 将 Java 替换为 HTML5,允许从任何网页浏览器访问, PC、Mac、iPhone、Android 或平板电脑,无需下载。该系统保留 24/7/365 全天候监控、警报通知和合规报告,同时提高跨设备的可用性和一致性。升级现已向新老客户开放。
- None.
- None.
Insights
Callan JMB released Sentry 4.0, a cross‑device HTML5 upgrade that increases accessibility for temperature‑sensitive monitoring.
The upgrade moves the proprietary Sentry platform from Java to Sentry 4.0 (HTML5), letting users access 24/7/365 monitoring, alarm notifications, and compliant reporting from any web browser on PC, Mac, iPhone, Android, or tablet. This preserves the existing active monitoring service model while removing the need to download client software, which simplifies operations for pharmacies, hospitals, and emergency preparedness facilities.
Key dependencies and risks include continued staff monitoring capacity and the security and browser‑compatibility performance of the new HTML5 interface; the announcement asserts improved accessibility and retained compliant reporting but does not disclose security certifications, latency metrics, or migration details. Watch deployment uptake and user feedback over the next
Sentry Monitoring System allows for remote monitoring of refrigerators, freezers, and clean room temperatures for high-value pharmaceutical products in pharmacies, hospitals, and emergency preparedness facilities
SPRING BRANCH, Texas, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that it has upgraded its proprietary Sentry Monitoring System technology with version 4.0 for temperature-sensitive storage to significantly increase flexibility and accessibility for its customers.
The Sentry Monitoring System is a platform that allows remote monitoring of refrigerators, freezers, and clean room temperatures for high-value pharmaceutical products in pharmacies, hospitals, and emergency preparedness facilities. The upgraded version, Sentry 4.0, provides the user with the same 24/7/365 active monitoring by Callan JMB staff, alarm notifications, and compliant reporting data that are currently available with the Sentry 3 system, but with improved accessibility for users on the go.
"We are constantly listening to customer feedback to ensure that our systems are more user-friendly and effective,” said William McBride, CIO of Callan JMB. “We heard from our customers that they needed increased flexibility, and with Sentry 4.0 moving from Java to HTML5, users can now access their monitoring data and manage alarms from any device with a web browser. Whether you're in the pharmacy, at home, or traveling, you have full control without downloading anything."
Sentry 4.0 allows users to access a consistent interface across all systems and devices - PC or Mac, an iPhone or Android, or any tablet. This flexibility enables the customer to address environmental anomalies in their pharmaceutical storage units from any available device, without having to download additional programs.
With Sentry 4.0, Callan JMB has raised the bar for secure, reliable, and easy-to-use temperature monitoring that is critical to the medical and pharmaceutical industries. The upgraded system is now available to new and existing customers.
About Callan JMB
Callan JMB is an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services to secure medical materials and protect patients and communities with compliant, safe, and effective medicines. Our combined expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance and emergency preparedness is unparalleled in the industry. We offer the Gold Standard in client experience with customizable interfaces, next-level reliability in shipping and environmental sustainability in our specialty packaging.
Forward-Looking Statement
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs, such as “will,” “should,” “would,” “may,” and “could,” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Investors and security holders are urged to read these documents free of charge on the SEC's website at: http://www.sec.gov. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, and disclaims any intention or obligation to update or revise any such forward-looking statements to reflect events or circumstances that subsequently occur, or of which the Company hereafter becomes aware.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
CallanJMB@kcsa.com
212.896.1254
